Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Goujard

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Journal Francais D'Ophtalmologie|December 2, 1998
[Incidence and evaluation of viral retinitis in patients infected with the HIV virus and treated with HIV protease inhibitors]M Labetoulle, C Goujard, E Frau, et al.
HIV Medicine|September 17, 2004
Recent changes in the management of primary HIV-1 infection: results from the French PRIMO cohortV Schiffer, C Deveau, L Meyer, et al.
European Journal of Haematology|December 18, 2007
Congenital dyserythropoietic anaemia, type I, in a Caucasian patient with retinal angioid streaks (homozygous Arg1042Trp mutation in codanin-1)H Tamary, H Offret, O Dgany, et al.
Clinical Pharmacology and Therapeutics|October 4, 2012
Effect of adherence as measured by MEMS, ritonavir boosting, and CYP3A5 genotype on atazanavir pharmacokinetics in treatment-naive HIV-infected patientsR M Savic, A Barrail-Tran, X Duval, et al.
AIDS (London, England)|May 24, 2001
Proviral HIV-1 DNA in subjects followed since primary HIV-1 infection who suppress plasma viral load after one year of highly active antiretroviral therapyN Ngo-Giang-Huong, C Deveau, I Da Silva, et al.
The Journal of Clinical Investigation|November 24, 1999
Weak anti-HIV CD8(+) T-cell effector activity in HIV primary infectionM Dalod, M Dupuis, J C Deschemin, et al.
HIV Medicine|November 16, 2006
Impact of highly active antiretroviral therapy on the maturation of anti-HIV-1 antibodies during primary HIV-1 infectionL Adalid-Peralta, L Grangeot-Keros, A Rudent, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 2, 2020
Factors associated with tuberculosis-associated haemophagocytic syndrome: a multicentre case-control studyN Lerolle, M Laanani, L Galicier, et al.
Epidemiology and Infection|July 26, 2006
Hepatitis B virus-human immunodeficiency virus co-infection in France: a cross-sectional multicentre studyD Sène, S Pol, L Piroth, et al.
La Revue De Medecine Interne|August 10, 2021
L Pacoureau, C Labeyrie, P Catalan, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Journal Francais D'Ophtalmologie|December 2, 1998
[Incidence and evaluation of viral retinitis in patients infected with the HIV virus and treated with HIV protease inhibitors]M Labetoulle, C Goujard, E Frau, et al.
HIV Medicine|September 17, 2004
Recent changes in the management of primary HIV-1 infection: results from the French PRIMO cohortV Schiffer, C Deveau, L Meyer, et al.
European Journal of Haematology|December 18, 2007
Congenital dyserythropoietic anaemia, type I, in a Caucasian patient with retinal angioid streaks (homozygous Arg1042Trp mutation in codanin-1)H Tamary, H Offret, O Dgany, et al.
Clinical Pharmacology and Therapeutics|October 4, 2012
Effect of adherence as measured by MEMS, ritonavir boosting, and CYP3A5 genotype on atazanavir pharmacokinetics in treatment-naive HIV-infected patientsR M Savic, A Barrail-Tran, X Duval, et al.
AIDS (London, England)|May 24, 2001
Proviral HIV-1 DNA in subjects followed since primary HIV-1 infection who suppress plasma viral load after one year of highly active antiretroviral therapyN Ngo-Giang-Huong, C Deveau, I Da Silva, et al.
The Journal of Clinical Investigation|November 24, 1999
Weak anti-HIV CD8(+) T-cell effector activity in HIV primary infectionM Dalod, M Dupuis, J C Deschemin, et al.
HIV Medicine|November 16, 2006
Impact of highly active antiretroviral therapy on the maturation of anti-HIV-1 antibodies during primary HIV-1 infectionL Adalid-Peralta, L Grangeot-Keros, A Rudent, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 2, 2020
Factors associated with tuberculosis-associated haemophagocytic syndrome: a multicentre case-control studyN Lerolle, M Laanani, L Galicier, et al.
Epidemiology and Infection|July 26, 2006
Hepatitis B virus-human immunodeficiency virus co-infection in France: a cross-sectional multicentre studyD Sène, S Pol, L Piroth, et al.
La Revue De Medecine Interne|August 10, 2021
L Pacoureau, C Labeyrie, P Catalan, et al.
Pageof 8